NO20092115L - Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on - Google Patents
Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-onInfo
- Publication number
- NO20092115L NO20092115L NO20092115A NO20092115A NO20092115L NO 20092115 L NO20092115 L NO 20092115L NO 20092115 A NO20092115 A NO 20092115A NO 20092115 A NO20092115 A NO 20092115A NO 20092115 L NO20092115 L NO 20092115L
- Authority
- NO
- Norway
- Prior art keywords
- octahydrobenzo
- isoxazol
- benzyl
- methyl
- salt
- Prior art date
Links
- ALQXIMVNPRVWQA-UHFFFAOYSA-N 3-benzyl-2-methyl-3,3a,5,6,7,7a-hexahydro-1,2-benzoxazol-4-one Chemical compound CN1OC2CCCC(=O)C2C1CC1=CC=CC=C1 ALQXIMVNPRVWQA-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 150000003891 oxalate salts Chemical class 0.000 abstract 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002920 convulsive effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002102A ITMI20062102A1 (it) | 2006-11-02 | 2006-11-02 | Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one |
| PCT/IB2007/003292 WO2008053326A1 (en) | 2006-11-02 | 2007-10-31 | A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20092115L true NO20092115L (no) | 2009-05-29 |
Family
ID=39145485
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20092115A NO20092115L (no) | 2006-11-02 | 2009-05-29 | Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on |
| NO20092114A NO20092114L (no) | 2006-11-02 | 2009-05-29 | Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20092114A NO20092114L (no) | 2006-11-02 | 2009-05-29 | Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20100069450A1 (enExample) |
| EP (2) | EP2094674B1 (enExample) |
| JP (2) | JP2010509309A (enExample) |
| KR (2) | KR20090082452A (enExample) |
| CN (2) | CN101535281A (enExample) |
| AT (2) | ATE502021T1 (enExample) |
| AU (2) | AU2007315832A1 (enExample) |
| BR (2) | BRPI0718392A2 (enExample) |
| CA (2) | CA2667515A1 (enExample) |
| DE (2) | DE602007013278D1 (enExample) |
| HR (2) | HRP20090477A2 (enExample) |
| IL (2) | IL198443A0 (enExample) |
| IT (1) | ITMI20062102A1 (enExample) |
| MX (2) | MX2009004294A (enExample) |
| NO (2) | NO20092115L (enExample) |
| NZ (2) | NZ577978A (enExample) |
| RS (2) | RS20090389A (enExample) |
| RU (2) | RU2009120724A (enExample) |
| WO (2) | WO2008053326A1 (enExample) |
| ZA (2) | ZA200903618B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2112142A1 (en) * | 2008-04-24 | 2009-10-28 | Abiogen Pharma S.p.A. | Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
| ITMI20080768A1 (it) * | 2008-04-24 | 2009-10-25 | Abiogen Pharma Spa | Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one |
| EP2218721A1 (en) * | 2009-02-11 | 2010-08-18 | LEK Pharmaceuticals d.d. | Novel salts of sitagliptin |
| WO2011010332A1 (en) * | 2009-07-23 | 2011-01-27 | Abiogen Pharma S.P.A. | Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof |
| US10131642B1 (en) * | 2015-01-30 | 2018-11-20 | Boehringer Ingelheim International Gmbh | Aldosterone synthase inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4161595A (en) * | 1978-10-02 | 1979-07-17 | Bristol-Myers Company | Levulinic acid salt |
| US4419358A (en) * | 1981-11-12 | 1983-12-06 | Mead Johnson & Company | Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it |
| GB2264299B (en) * | 1992-02-19 | 1995-07-26 | British Tech Group | Iso-oxazolidine derivatives |
-
2006
- 2006-11-02 IT IT002102A patent/ITMI20062102A1/it unknown
-
2007
- 2007-10-31 KR KR1020097011322A patent/KR20090082452A/ko not_active Withdrawn
- 2007-10-31 CA CA002667515A patent/CA2667515A1/en not_active Abandoned
- 2007-10-31 DE DE602007013278T patent/DE602007013278D1/de active Active
- 2007-10-31 WO PCT/IB2007/003292 patent/WO2008053326A1/en not_active Ceased
- 2007-10-31 JP JP2009535824A patent/JP2010509309A/ja active Pending
- 2007-10-31 CN CNA2007800406598A patent/CN101535281A/zh active Pending
- 2007-10-31 AT AT07825549T patent/ATE502021T1/de not_active IP Right Cessation
- 2007-10-31 RS RSP-2009/0389A patent/RS20090389A/sr unknown
- 2007-10-31 AU AU2007315832A patent/AU2007315832A1/en not_active Abandoned
- 2007-10-31 RU RU2009120724/04A patent/RU2009120724A/ru not_active Application Discontinuation
- 2007-10-31 MX MX2009004294A patent/MX2009004294A/es not_active Application Discontinuation
- 2007-10-31 US US12/513,351 patent/US20100069450A1/en not_active Abandoned
- 2007-10-31 CN CNA2007800406691A patent/CN101535282A/zh active Pending
- 2007-10-31 EP EP07825549A patent/EP2094674B1/en not_active Not-in-force
- 2007-10-31 BR BRPI0718392-5A patent/BRPI0718392A2/pt not_active IP Right Cessation
- 2007-10-31 HR HR20090477A patent/HRP20090477A2/hr not_active Application Discontinuation
- 2007-10-31 RU RU2009120667/04A patent/RU2009120667A/ru not_active Application Discontinuation
- 2007-10-31 MX MX2009004293A patent/MX2009004293A/es not_active Application Discontinuation
- 2007-10-31 AU AU2007315833A patent/AU2007315833A1/en not_active Abandoned
- 2007-10-31 HR HR20090470A patent/HRP20090470A2/hr not_active Application Discontinuation
- 2007-10-31 JP JP2009535825A patent/JP2010509310A/ja active Pending
- 2007-10-31 BR BRPI0718391-7A patent/BRPI0718391A2/pt not_active IP Right Cessation
- 2007-10-31 NZ NZ577978A patent/NZ577978A/en unknown
- 2007-10-31 DE DE602007013801T patent/DE602007013801D1/de active Active
- 2007-10-31 NZ NZ577311A patent/NZ577311A/en unknown
- 2007-10-31 KR KR1020097011287A patent/KR20090077014A/ko not_active Withdrawn
- 2007-10-31 EP EP07825550A patent/EP2094675B1/en not_active Not-in-force
- 2007-10-31 US US12/513,352 patent/US20100069451A1/en not_active Abandoned
- 2007-10-31 AT AT07825550T patent/ATE504578T1/de not_active IP Right Cessation
- 2007-10-31 CA CA002667513A patent/CA2667513A1/en not_active Abandoned
- 2007-10-31 RS RSP-2009/0388A patent/RS20090388A/sr unknown
- 2007-10-31 WO PCT/IB2007/003291 patent/WO2008053325A1/en not_active Ceased
-
2009
- 2009-04-28 IL IL198443A patent/IL198443A0/en unknown
- 2009-04-28 IL IL198444A patent/IL198444A0/en unknown
- 2009-05-25 ZA ZA200903618A patent/ZA200903618B/xx unknown
- 2009-05-29 NO NO20092115A patent/NO20092115L/no not_active Application Discontinuation
- 2009-05-29 NO NO20092114A patent/NO20092114L/no not_active Application Discontinuation
- 2009-06-01 ZA ZA200903810A patent/ZA200903810B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0302232D0 (sv) | Novel Compounds | |
| ATE542818T1 (de) | Imidazo- und triazolopyridinverbindungen und verfahren zu deren anwendung | |
| DE602006021645D1 (de) | Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten | |
| SE0201635D0 (sv) | Novel compounds | |
| ATE431340T1 (de) | N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1- piperidincarboxamid-derivate und verwandte verbindungen als cgrp-antagonisten zur behandlung von kopfschmerzen | |
| SE0301010D0 (sv) | Novel compounds | |
| SE0202241D0 (sv) | Novel Compounds | |
| SE0301009D0 (sv) | Novel compounds | |
| EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
| TW200700068A (en) | Phthalazine, aza-and diaza-phthalazine compounds and methods of use | |
| PL1716152T3 (pl) | Skondensowane związki heterocykliczne i ich zastosowanie jako antagonistów receptora metabotropowego do leczenia zaburzeń żołądkowo-jelitowych | |
| NO20092115L (no) | Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on | |
| ATE318813T1 (de) | Neue kristalline formen von meloxicam, deren herstellung und verfahren zu deren umwandlung ineinander | |
| ATE502945T1 (de) | Ä ä5- ( phenyl) - 6- phenylpyrrolo ä2,1-füä2,1, 4ütriazin-4-ylüaminoü carbonsäurederivate und verwandte verbindungen als prostazyklin (pgi2) ip-rezeptor aktivatoren zur behandlung von kardiovaskulären erkrankungen | |
| NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
| DE60312029D1 (de) | Verfahren zur herstellung c-7 substituierter 5-androstene | |
| EA200600563A1 (ru) | Способ получения рензаприда и его промежуточных соединений | |
| HK1131142A (en) | A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one | |
| HK1131143A (en) | A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one | |
| PL2186782T3 (pl) | Sposób oczyszczania produktów znakowanych radioaktywnie z zastosowaniem zmiatacza na stałym nośniku | |
| ATE481408T1 (de) | Reinigung von beta-lactam-verbindungen | |
| DK1873152T3 (da) | Hidtil ukendt fremgangsmåde til oprensning af Moxonidin | |
| BRPI0513468A (pt) | método de produção de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodia-zepin-2 (1h)-ona | |
| SE0303451D0 (sv) | New compounds | |
| EA200602082A1 (ru) | Производные индол-2-она для лечения расстройств центральной нервной системы, желудочно-кишечных расстройств и сердечно-сосудистых расстройств |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |